COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Comment by slagheapon Sep 11, 2015 4:35pm

103 Views

Post# 24097551

RE:RE:RE:RE:what a disaster

Todays low for AEZS was 0.0581 and when it slips below 0.05 the warrant holders will attempt to maximize their return by selling in the range of 0.045 to 0.05 possibly meaning a share price below 0.07 for AEZ is a buy.

Potential shares from series B warrants based on VWAP or $0.05 (754,858,824).

Bullboard Posts

Gold, growth and sustainability in focus for Mandalay Resources